As shown in Supplementary Fig. 2, overexpression of ADAM-17 enhanced the subcutaneous growth of MHCC97-H cells in nude mice and decreased the antitumor effect of sorafenib on HCC cells. Here, ADAM17 is linked to hepatocellular carcinoma.